132 related articles for article (PubMed ID: 20598555)
1. 2-phenyl-1-[4-(2-piperidine-1-yl-ethoxy)benzyl]-1H-benzimidazoles as ligands for the estrogen receptor: synthesis and pharmacological evaluation.
Dettmann S; Szymanowitz K; Wellner A; Schiedel A; Müller CE; Gust R
Bioorg Med Chem; 2010 Jul; 18(14):4905-16. PubMed ID: 20598555
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation.
Thimmegowda NR; Nanjunda Swamy S; Kumar CS; Kumar YC; Chandrappa S; Yip GW; Rangappa KS
Bioorg Med Chem Lett; 2008 Jan; 18(1):432-5. PubMed ID: 17981032
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological evaluation of 1H-imidazoles as ligands for the estrogen receptor and cytotoxic inhibitors of the cyclooxygenase.
Wiglenda T; Ott I; Kircher B; Schumacher P; Schuster D; Langer T; Gust R
J Med Chem; 2005 Oct; 48(20):6516-21. PubMed ID: 16190777
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
6. Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
Sondhi SM; Rani R; Singh J; Roy P; Agrawal SK; Saxena AK
Bioorg Med Chem Lett; 2010 Apr; 20(7):2306-10. PubMed ID: 20188544
[TBL] [Abstract][Full Text] [Related]
7. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
8. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
9. Microwave-assisted synthesis of sec/tert-butyl 2-arylbenzimidazoles and their unexpected antiproliferative activity towards ER negative breast cancer cells.
Abdul Rahim AS; Salhimi SM; Arumugam N; Pin LC; Yee NS; Muttiah NN; Keat WB; Abd Hamid S; Osman H; Mat Ib
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1255-60. PubMed ID: 23061895
[TBL] [Abstract][Full Text] [Related]
10. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G
J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
12. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
Rousseau C; Nichol JN; Pettersson F; Couture MC; Miller WH
Mol Cancer Res; 2004 Sep; 2(9):523-31. PubMed ID: 15383631
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
Treeck O; Lattrich C; Springwald A; Ortmann O
Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells.
Jacquot Y; Laïos I; Cleeren A; Nonclercq D; Bermont L; Refouvelet B; Boubekeur K; Xicluna A; Leclercq G; Laurent G
Bioorg Med Chem; 2007 Mar; 15(6):2269-82. PubMed ID: 17275315
[TBL] [Abstract][Full Text] [Related]
15. First synthesis of an aziridinyl fused pyrrolo[1,2-a]benzimidazole and toxicity evaluation towards normal and breast cancer cell lines.
Bonham S; O'Donovan L; Carty MP; Aldabbagh F
Org Biomol Chem; 2011 Oct; 9(19):6700-6. PubMed ID: 21808774
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands.
Stope MB; Popp SL; Knabbe C; Buck MB
Breast Cancer Res Treat; 2010 Apr; 120(2):357-67. PubMed ID: 19370415
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Schiff bases related to benzimidazoles.
Hranjec M; Starčević K; Pavelić SK; Lučin P; Pavelić K; Karminski Zamola G
Eur J Med Chem; 2011 Jun; 46(6):2274-9. PubMed ID: 21439689
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives.
Refaat HM
Eur J Med Chem; 2010 Jul; 45(7):2949-56. PubMed ID: 20399544
[TBL] [Abstract][Full Text] [Related]
19. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells.
Lee SO; Nadiminty N; Wu XX; Lou W; Dong Y; Ip C; Onate SA; Gao AC
Cancer Res; 2005 Apr; 65(8):3487-92. PubMed ID: 15833885
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid restores ER alpha and antiestrogen sensitivity to ER alpha-negative breast cancer cells.
Fortunati N; Bertino S; Costantino L; De Bortoli M; Compagnone A; Bandino A; Catalano MG; Boccuzzi G
Mol Cell Endocrinol; 2010 Jan; 314(1):17-22. PubMed ID: 19772891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
